Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic Dermatitis
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate dose response, safety, tolerability and efficacy of
2.5% and 5% cis-UCA in comparison to placebo and active comparator in the treatment of adult
patients with moderate or severe chronic atopic dermatitis.